MedTrace Logo

Effect of Fu's Subcutaneous Needling for Age-related Macular Degeneration

NCT07121127 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2025-08-13

No results posted yet for this study

Summary

This pilot randomized controlled trial aims to evaluate the efficacy and safety of FSN in improving symptoms in patients with dAMD.38 eligible participants will be recruited and randomly assign them in a 1:1 ratio to the FSN group and the control group. Throughout the study, both groups will take oral vitamin C and vitamin E supplements for a total of 28 days. Participants in the FSN group will receive four treatment sessions over two weeks. Both groups will be assessed at the end of the FSN treating period during the mid-study period, with ocular blood flow dynamics measured using OCTA, followed by a two-week follow-up. The primary outcome of this trial is the change in visual acuity from baseline to week 2, with secondary outcomes including visual field, visual function scale, macular thickness, central avascular zone area vascular density, and choroidal thickness.

Conditions

  • Age - Related Macular Degeneration (AMD)

Interventions

COMBINATION_PRODUCT

FSN+Vitamin supplement

Fu's subcutaneous needling with oral Vitamin C and vitamin E supplements

DRUG

Vitamin Supplements

oral Vitamin C and vitamin E supplements

Sponsors & Collaborators

  • Zhiming Yan

    lead OTHER

Principal Investigators

  • Jian Sun · Guangzhou University of Chinese Medicine - Department of Acupuncture and Rehabilitation Clinical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-07
Primary Completion
2029-08-08
Completion
2030-03-09

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07121127 on ClinicalTrials.gov